EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Agreement of Administrative Pharmacy Dispensing With Self‐Reported Use of Oral Prednisone in US Veterans With Rheumatoid Arthritis

Beth I Wallace iD, Bryant R England iD, Joshua F Baker, Michael D George iD, Brian C Sauer iD, Jorge Rojas, Punyasha Roul, Katherine D Wysham, Hannah Brubeck, Isaac Smith, Liron Caplan, Paul A Monach iD und 5 weitere

Arthritis Care & Research · 2025

DOI: 10.1002/acr.25580 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Arthritis Care & Research, 2025. Verfasst von Beth I Wallace und 16 weiteren Autor:innen. Beteiligte Einrichtung: VA Ann Arbor Healthcare System and University of Michigan, Ann Arbor, Michigan. Hauptthemen laut MEDLINE: Prednisone, Arthritis, Rheumatoid, Self Report, Veterans. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, CSRD VA, RRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Administrative claims are used to evaluate oral glucocorticoid use in rheumatoid arthritis (RA), despite limited evidence to support accuracy. We aimed to evaluate the performance of claims‐based algorithms for glucocorticoid use compared to self‐report in an RA population.

Methods

Participants with RA enrolled at seven Veterans Affairs Rheumatoid Arthritis (VARA) Registry sites were asked six questions as part of clinical care assessing current prednisone use and dose, recent use, “stockpiling,” and receiving prednisone outside the Department of Veterans Affairs (VA). Algorithms using VA prescription claims operationalized current use (active prescription on date of self‐report assessment), current dose (that prescription's mean dose), and recent use (active course overlapping the prior 30 or 90 days). We assessed performance characteristics and agreement, benchmarked on self‐report.

Results

Of 284 participants, 13% reported current prednisone use and 20% reported 90‐day use. Sensitivity, specificity, positive predictive value, and negative predictive value were 0.70, 0.98, 0.84, and 0.96, respectively, for current use and 0.71, 0.92, 0.72, and 0.92, respectively, for 90‐day use. Cohen's κ was 0.68 for current use and 0.63 for 90‐day use. Among participants reporting ≤5 mg/day, agreement for dose was high (weighted κ 0.67). One in four participants reported a stockpile, and one in four reported receiving prednisone from a non‐VA provider.

Conclusion

Algorithms derived from VA claims detecting prednisone prescriptions have high validity compared to patient self‐report. The modest sensitivity of these algorithms may reflect stockpiling and non‐VA prescriptions. These findings form a basis for contextualizing real‐world studies of glucocorticoid use in RA and improve clinical estimation of glucocorticoid use not captured in claims.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PrednisoneArthritis, RheumatoidSelf ReportVeteransGlucocorticoidsHumansMaleUnited StatesFemaleMiddle AgedAgedAdministration, OralAlgorithmsRegistries

Substanzen

PrednisoneGlucocorticoids

Autor:innen und Institutionen

  • VA Ann Arbor Healthcare System and University of Michigan, Ann Arbor, Michigan.
  • VA Nebraska-Western Iowa Healthcare System and University of Nebraska Medical Center, Omaha, Nebraska.
  • Hospital of the University of Pennsylvania and VA Philadelphia Healthcare System, Philadelphia, Pennsylvania.
  • Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • VA Salt Lake City Healthcare System and University of Utah, Salt Lake City, Utah.
  • VA Salt Lake City Healthcare System, Salt Lake City, Utah, and VA Puget Sound Health Care System, Seattle, Washington.

ORCID-Profile: Beth I Wallace, Bryant R England, Michael D George, Brian C Sauer, Paul A Monach, Gail S Kerr, Ted R Mikuls, Grant W Cannon

Förderung

  • NIGMS NIH HHS
  • CSRD VA
  • RRD VA
  • BLRD VA
  • NIMHD NIH HHS
  • Rheumatology Research Foundation
  • U.S. Department of Veterans Affairs
  • Duke University

Zitieren

APA

Wallace, B. I., England, B. R., Baker, J. F., George, M. D., Sauer, B. C., Rojas, J., Roul, P., Wysham, K. D., Brubeck, H., Smith, I., Caplan, L., Monach, P. A., Kerr, G. S., Kunkel, G., Braaten, T., Mikuls, T. R., & Cannon, G. W. (2025). Agreement of Administrative Pharmacy Dispensing With Self‐Reported Use of Oral Prednisone in US Veterans With Rheumatoid Arthritis. Arthritis Care & Research. https://doi.org/10.1002/acr.25580

Vancouver

Wallace BI, England BR, Baker JF, George MD, Sauer BC, Rojas J, et al. Agreement of Administrative Pharmacy Dispensing With Self‐Reported Use of Oral Prednisone in US Veterans With Rheumatoid Arthritis. Arthritis Care & Research. 2025. doi:10.1002/acr.25580

BibTeX
@article{Wallace2025,
  author = {Wallace, Beth I and England, Bryant R and Baker, Joshua F and George, Michael D and Sauer, Brian C and Rojas, Jorge and Roul, Punyasha and Wysham, Katherine D and Brubeck, Hannah and Smith, Isaac and Caplan, Liron and Monach, Paul A and Kerr, Gail S and Kunkel, Gary and Braaten, Tawnie and Mikuls, Ted R and Cannon, Grant W},
  title = {Agreement of Administrative Pharmacy Dispensing With Self‐Reported Use of Oral Prednisone in US Veterans With Rheumatoid Arthritis},
  journal = {Arthritis Care & Research},
  year = {2025},
  doi = {10.1002/acr.25580}
}
Kostenlos starten →